Menu
Back to Journals » Biologics: Targets and Therapy » Volume 12
Review
Two decades with omalizumab: what we still have to learn
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 19,382 | Dovepress* | 14,873+ | 1,535 | 16,408 | |
| PubMed Central* | 4,509 | 890 | 5,399 | ||
| Totals | 19,382 | 2,425 | 21,807 | ||
| *Since 26 October 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar